Calibration Methods Used in Cancer Simulation Models and Suggested Reporting Guidelines
暂无分享,去创建一个
Natasha K. Stout | Chung Yin Kong | G. Scott Gazelle | Amy B. Knudsen | Pamela M. McMahon | G. Gazelle | N. Stout | A. Knudsen | C. Kong | P. McMahon | Amy B. Knudsen | Natasha K Stout | Chung Yin Kong
[1] John A. Nelder,et al. A Simplex Method for Function Minimization , 1965, Comput. J..
[2] B. Kintz,et al. Computational Handbook of Statistics , 1968 .
[3] D. Nash. Problems and Progress in Medical Care , 1969 .
[4] John H. Holland,et al. Adaptation in Natural and Artificial Systems: An Introductory Analysis with Applications to Biology, Control, and Artificial Intelligence , 1992 .
[5] A. Miller,et al. Optimising the age, number of tests, and test interval for cervical screening in Canada. , 1982, Journal of epidemiology and community health.
[6] Averill M. Law,et al. Simulation Modeling and Analysis , 1982 .
[7] J. Habbema,et al. Cost-effectiveness of cervical cancer screening. , 1983, Connecticut medicine.
[8] C. D. Gelatt,et al. Optimization by Simulated Annealing , 1983, Science.
[9] J D Habbema,et al. Model building on the basis of Dutch cervical cancer screening data. , 1985, Maturitas.
[10] D. Parkin. A computer simulation model for the practical planning of cervical cancer screening programmes. , 1985, British Journal of Cancer.
[11] A. J. Valleron,et al. A simulation model of the natural history of human breast cancer. , 1985, British Journal of Cancer.
[12] D M Parkin,et al. An evaluation of screening policies for cervical cancer in England and Wales using a computer simulation model. , 1986, Journal of epidemiology and community health.
[13] D M Eddy,et al. The frequency of cervical cancer screening. Comparison of a mathematical model with empirical data , 1987, Cancer.
[14] J. D. F. Habbema,et al. A simulation approach to cost-effectiveness and cost-benefit calculations of screening for the early detection of disease , 1987 .
[15] M. Kimmel,et al. The natural history of lung cancer in a periodically screened population. , 1987, Biometrics.
[16] David E. Goldberg,et al. Genetic Algorithms in Search Optimization and Machine Learning , 1988 .
[17] D. F. Wong,et al. Simulated Annealing for VLSI Design , 1988 .
[18] Natural history of adenocarcinoma-large cell carcinoma of the lung: conclusions from screening programs in New York and Baltimore. , 1988, Journal of the National Cancer Institute.
[19] E. Knox. Evaluation of a proposed breast cancer screening regimen. , 1988, BMJ.
[20] D. Eddy. Screening for breast cancer. , 1989, Annals of internal medicine.
[21] H. Adami,et al. Natural history of cervical neoplasia: consistent results obtained by an identification technique. , 1989, British Journal of Cancer.
[22] V Sreenivas,et al. A simulation approach for estimating the loss of womanyears due to cervical cancer and probability of developing cervical cancer. , 1989, Neoplasma.
[23] J. Habbema,et al. The cost‐effectiveness of breast cancer screening , 1989, International journal of cancer.
[24] Fred W. Glover,et al. Tabu Search - Part I , 1989, INFORMS J. Comput..
[25] D. Eddy. Screening for cervical cancer. , 1990, Annals of internal medicine.
[26] J D Habbema,et al. A model for breast cancer screening , 1990, Cancer.
[27] J. Habbema,et al. A model‐based analysis of the hip project for breast cancer screening , 1990, International journal of cancer.
[28] Fred Glover,et al. Tabu Search - Part II , 1989, INFORMS J. Comput..
[29] S. Koscielny,et al. The natural history of breast cancer: implications for a screening strategy. , 1990, International journal of radiation oncology, biology, physics.
[30] M A Koopmanschap,et al. Economic aspects of cervical cancer screening. , 1990, Social science & medicine.
[31] H. Adami,et al. Cytologic screening for cancer of the uterine cervix in Sweden evaluated by identification and simulation. , 1990, British Journal of Cancer.
[32] D. Singer,et al. Quantifying the potential benefit of CA 125 screening for ovarian cancer. , 1991, Journal of clinical epidemiology.
[33] M Kimmel,et al. Nonparametric estimation of the size-metastasis relationship in solid cancers. , 1991, Biometrics.
[34] P. Skrabanek. The Cost-effectiveness of Breast Cancer Screening , 1991, International Journal of Technology Assessment in Health Care.
[35] H. D. de Koning,et al. Breast cancer screening and cost‐effectiveness; Policy alternatives, quality of life considerations and the possible impact of uncertain factors , 1991, International journal of cancer.
[36] J. Wagner,et al. Cost effectiveness of colorectal cancer screening in the elderly. , 1991, Annals of internal medicine.
[37] H. Glick,et al. Cost‐effectiveness analysis of mass screening for breast cancer in Japan , 1991, Cancer.
[38] William H. Press,et al. Numerical Recipes in C, 2nd Edition , 1992 .
[39] A 50‐Year Projection of Lung Cancer Deaths among Japanese Males and Potential Impact Evaluation of Anti‐smoking Measures and Screening Using a Computerized Simulation Model , 1992, Japanese journal of cancer research : Gann.
[40] Bruce E. Rosen,et al. Genetic Algorithms and Very Fast Simulated Reannealing: A comparison , 1992 .
[41] S. Mader. Influence of animal age on the beta-adrenergic system in cultured rat aortic and mesenteric artery smooth muscle cells. , 1992, Journal of gerontology.
[42] J. Beck,et al. Effect of the Clinical Laboratory Improvement Amendments of 1988 (CLIA '88) on the Incidence of Invasive Cervical Cancer , 1992, Medical care.
[43] K. Manton,et al. Demographics (1950-1987) of breast cancer in birth cohorts of older women. , 1992, Journal of gerontology.
[44] R Levine,et al. Prevention and early detection of colorectal cancer. , 1992, American family physician.
[45] P. Glasziou,et al. Cost-effectiveness of mammographic screening in Australia. , 2010, Australian journal of public health.
[46] M Kimmel,et al. Screening for lung cancer: The Mayo lung project revisited , 1993, Cancer.
[47] M. Cowen,et al. A Markov model of the natural history of prostate cancer. , 1994, Journal of clinical epidemiology.
[48] S G Pauker,et al. Screening for prostate cancer. A decision analytic view. , 1994, JAMA.
[49] S Mizuno,et al. Evaluation of cancer prevention strategies by computerized simulation model: methodological issues. , 1994, Environmental health perspectives.
[50] D. Gyrd-Hansen,et al. A cost-effectiveness analysis of cervical cancer screening: health policy implications. , 1995, Health policy.
[51] D. Whynes,et al. Cost-effectiveness of screening for colorectal cancer: a simulation model. , 1995, IMA journal of mathematics applied in medicine and biology.
[52] J. Zoetelief,et al. MBS: a model for risk benefit analysis of breast cancer screening. , 1995, The British journal of radiology.
[53] László Tabár,et al. Quantitative Interpretation of Age-Specific Mortality Reductions From the Swedish Breast Cancer-Screening Trials , 1995 .
[54] J. Habbema,et al. A model-based prediction of the impact on reduction in mortality by a breast cancer screening programme in the city of Florence, Italy. , 1995, European journal of cancer.
[55] H. D. de Koning,et al. Quantitative interpretation of age-specific mortality reductions from the Swedish breast cancer-screening trials. , 1995, Journal of the National Cancer Institute.
[56] N. Devlin,et al. The cost-effectiveness of mammography screening: evidence from a microsimulation model for New Zealand. , 1996, Health policy.
[57] C B Schechter,et al. Cost-effectiveness of rescreening conventionally prepared cervical smears by PAPNET testing. , 1996, Acta cytologica.
[58] R W Sanson-Fisher,et al. Screening for Melanoma by Primary Health Care Physicians: A Cost—Effectiveness Analysis , 1996, Journal of medical screening.
[59] Theodore W. Manikas,et al. Genetic Algorithms vs. Simulated Annealing: A Comparison of Approaches for Solving the Circuit Partitioning Problem , 1996 .
[60] N Urban,et al. Use of a stochastic simulation model to identify an efficient protocol for ovarian cancer screening. , 1997, Controlled clinical trials.
[61] J. Zoetelief,et al. Assessment of lifetime gained as a result of mammographic breast cancer screening using a computer model. , 1997, The British journal of radiology.
[62] D. Gyrd-Hansen,et al. Analysis of screening data: colorectal cancer. , 1997, International journal of epidemiology.
[63] J Zoetelief,et al. Optimisation of mammographic breast cancer screening using a computer simulation model. , 1997, European journal of radiology.
[64] I. Tsuji,et al. Cost-effective analysis of mass screening for cervical cancer in Japan. , 1997, Journal of epidemiology.
[65] M. Downer,et al. An interim determination of health gain from oral cancer and precancer screening: 2. Developing a model of population screening. , 1997, Community dental health.
[66] Jerry Banks,et al. Handbook of simulation - principles, methodology, advances, applications, and practice , 1998, A Wiley-Interscience publication.
[67] R. Boer,et al. Cost Effectiveness of Shortening Screening Interval or Extending Age Range of NHS Breast Screening Programme , 1999 .
[68] D. Whynes,et al. Faecal occult blood screening for colorectal cancer: is it cost-effective? , 1998, Health economics.
[69] D. Gyrd-Hansen,et al. Colorectal cancer screening: efficiency and effectiveness. , 1998, Health economics.
[70] Paul W. Radensky,et al. Interactive Neural Network–Assisted Screening , 1998, Acta Cytologica.
[71] H. D. de Koning,et al. Radiation risk of mammography related to benefit in screening programmes: a favourable balance? , 1998, Journal of medical screening.
[72] L. Mango,et al. Interactive Neural Network–Assisted Screening , 1998, Acta Cytologica.
[73] R. Baker,et al. Use of a mathematical model to evaluate breast cancer screening policy , 1998, Health care management science.
[74] M. Weinstein,et al. The Costs, Clinical Benefits, and Cost-Effectiveness of Screening for Cervical Cancer in HIV-Infected Women , 1999, Annals of Internal Medicine.
[75] P. J. van der Maas,et al. Stage distribution at first and repeat examinations in breast cancer screening , 1999, Journal of medical screening.
[76] D B Kopans,et al. Breast cancer: computer simulation method for estimating optimal intervals for screening. , 1999, Radiology.
[77] Rob Boer,et al. The MISCAN-COLON Simulation Model for the Evaluation of Colorectal Cancer Screening , 1999, Comput. Biomed. Res..
[78] M. Cowen,et al. Serial prostate specific antigen screening for prostate cancer: a computer model evaluates competing strategies. , 1999, The Journal of urology.
[79] Shinji Sato,et al. Determining the Cost-Effectiveness of Mass Screening for Cervical Cancer Using Common Analytic Models , 1999, Acta Cytologica.
[80] B. Bloom,et al. Clinical and economic effects of population-based Helicobacter pylori screening to prevent gastric cancer. , 1999, Archives of internal medicine.
[81] E. Feuer,et al. Cancer surveillance series: interpreting trends in prostate cancer--part III: Quantifying the link between population prostate-specific antigen testing and recent declines in prostate cancer mortality. , 1999, Journal of the National Cancer Institute.
[82] D. Jenkins,et al. Withdrawing low risk women from cervical screening programmes: mathematical modelling study. , 1999, BMJ.
[83] Ruth Etzioni,et al. Simulation modeling of outcomes and cost effectiveness. , 2000, Hematology/oncology clinics of North America.
[84] M Arbyn,et al. Overview of important cervical cancer screening process values in European Union (EU) countries, and tentative predictions of the corresponding effectiveness and cost-effectiveness. , 2000, European journal of cancer.
[85] H A Guess,et al. Comparative efficiency of prostate-specific antigen screening strategies for prostate cancer detection. , 2000, JAMA.
[86] P. Prorok,et al. Investigation of design and bias issues in case-control studies of cancer screening using microsimulation. , 2000, American journal of epidemiology.
[87] J. Mitchell,et al. A DECISION MODEL AND COST-EFFECTIVENESS ANALYSIS OF COLORECTAL CANCER SCREENING AND SURVEILLANCE GUIDELINES FOR AVERAGE-RISK ADULTS , 2000, International Journal of Technology Assessment in Health Care.
[88] Graham A. Colditz,et al. Cost-effectiveness of screening for colorectal cancer in the general population. , 2000, JAMA.
[89] Robert W. Klein,et al. Cost-utility of one-time colonoscopic screening for colorectal cancer at various ages , 2000 .
[90] J D Habbema,et al. Endoscopic colorectal cancer screening: a cost-saving analysis. , 2000, Journal of the National Cancer Institute.
[91] D C McCrory,et al. Mathematical model for the natural history of human papillomavirus infection and cervical carcinogenesis. , 2000, American journal of epidemiology.
[92] C. Henschke,et al. Modeling of long‐term screening for lung carcinoma , 2001, Cancer.
[93] C. Earle,et al. Potential cost-effectiveness of one-time screening for lung cancer (LC) in a high risk cohort. , 2000, Lung cancer.
[94] J. Habbema,et al. Impact of systematic false-negative test results on the performance of faecal occult blood screening. , 2001, European journal of cancer.
[95] D. Pauler,et al. Screening Based on the Risk of Cancer Calculation From Bayesian Hierarchical Changepoint and Mixture Models of Longitudinal Markers , 2001 .
[96] T. Wright,et al. Policy analysis of cervical cancer screening strategies in low-resource settings: clinical benefits and cost-effectiveness. , 2001, JAMA.
[97] S K Plevritis,et al. A mathematical algorithm that computes breast cancer sizes and doubling times detected by screening. , 2001, Mathematical biosciences.
[98] R. Hayward,et al. Which colon cancer screening test? A comparison of costs, effectiveness, and compliance. , 2001, The American journal of medicine.
[99] Computer modelling of the Swedish two county trial of mammographic screening and trade offs between participation and screening interval , 2001, Journal of medical screening.
[100] Grace Huang,et al. Aspirin as an Adjunct to Screening for Prevention of Sporadic Colorectal Cancer: A Cost-Effectiveness Analysis , 2001, Annals of Internal Medicine.
[101] Christopher J. Lacke,et al. Analysis of Colorectal Cancer Screening Regimens , 2001, Health Care Management Science.
[102] Tony Hsiu-Hsi Chen,et al. Assessing chronic disease progression using non‐homogeneous exponential regression Markov models: an illustration using a selective breast cancer screening in Taiwan , 2002, Statistics in Medicine.
[103] W. Lawrence,et al. Benefits and costs of using HPV testing to screen for cervical cancer. , 2002, JAMA.
[104] T. Wright,et al. Cost-effectiveness of alternative triage strategies for atypical squamous cells of undetermined significance. , 2002, JAMA.
[105] William H. Press,et al. Numerical recipes in C , 2002 .
[106] W. Lawrence,et al. Costs and benefits of different strategies to screen for cervical cancer in less-developed countries. , 2002, Journal of the National Cancer Institute.
[107] Ruth Davies,et al. A Simulation to Evaluate Screening for Helicobacter Pylori Infection in the Prevention of Peptic Ulcers and Gastric Cancers , 2002, Health care management science.
[108] S. Goldie. Public health policy and cost-effectiveness analysis , 2003 .
[109] N. Nagelkerke,et al. Prevalence of family histories of breast cancer in the general population and the incidence of related seeking of health care , 2003, Journal of medical genetics.
[110] S. Goldie. Chapter 15: Public health policy and cost-effectiveness analysis. , 2003, Journal of the National Cancer Institute. Monographs.
[111] J. Faivre,et al. A simulation model for evaluating the medical and economic outcomes of screening strategies for colorectal cancer , 2003, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.
[112] E. Halpern,et al. Estimates of Breast Cancer Growth Rate and Sojourn Time from Screening Database Information , 2003 .
[113] Harry J de Koning,et al. Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer. , 2003, Journal of the National Cancer Institute.
[114] P. Roderick,et al. The cost-effectiveness of screening for Helicobacter pylori to reduce mortality and morbidity from gastric cancer and peptic ulcer disease: a discrete-event simulation model. , 2003, Health Technology Assessment.
[115] P. Walsh,et al. Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends. , 2003, The Journal of urology.
[116] Analysis of benefit:risk ratio and mortality reduction for the UK Breast Screening Programme. , 2003, The British journal of radiology.
[117] Cost-effectiveness of population screening for Helicobacter pylori in preventing gastric cancer and peptic ulcer disease, using simulation. , 2003, Journal of medical screening.
[118] H. D. de Koning,et al. MISCAN: estimating lead‐time and over‐detection by simulation , 2003, BJU international.
[119] M. Weinstein,et al. A comprehensive natural history model of HPV infection and cervical cancer to estimate the clinical impact of a prophylactic HPV‐16/18 vaccine , 2003, International journal of cancer.
[120] Daniel B. Kopans,et al. Estimates of the Sizes at Which Breast Cancers Become Detectable on Mammographic and Clinical Grounds , 2003 .
[121] A. Fendrick,et al. Potential effect of cyclooxygenase-2-specific inhibitors on the prevention of colorectal cancer: a cost-effectiveness analysis. , 2003, The American journal of medicine.
[122] L. Tabár,et al. Bayesian evaluation of breast cancer screening using data from two studies , 2003, Statistics in medicine.
[123] K. Kerlikowske,et al. Risk of cervical cancer associated with extending the interval between cervical-cancer screenings. , 2003, The New England journal of medicine.
[124] John Eng,et al. Lung cancer screening with helical computed tomography in older adult smokers: a decision and cost-effectiveness analysis. , 2003, JAMA.
[125] Milton C Weinstein,et al. Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR Task Force on Good Research Practices--Modeling Studies. , 2003, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[126] Frank Castro,et al. A computer model for the study of breast cancer , 2003, Comput. Biol. Medicine.
[127] Louis P Garrison. The ISPOR Good Practice Modeling Principles--a sensible approach: be transparent, be reasonable. , 2003, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[128] W. Lawrence,et al. The balance of harms, benefits, and costs of screening for cervical cancer in older women: the case for continued screening. , 2004, Archives of internal medicine.
[129] Milton C Weinstein,et al. Projected clinical benefits and cost-effectiveness of a human papillomavirus 16/18 vaccine. , 2004, Journal of the National Cancer Institute.
[130] T. Wright,et al. Cost-Effectiveness of Human Papillomavirus DNA Testing for Cervical Cancer Screening in Women Aged 30 Years or More , 2004, Obstetrics and gynecology.
[131] Peter Muennig,et al. Benefits and costs of interventions to improve breast cancer outcomes in African American women. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[132] E. Feuer,et al. The use of modeling to understand the impact of screening on US mortality: examples from mammography and PSA testing , 2004, Statistical methods in medical research.
[133] H. D. de Koning,et al. Trends in the usage of adjuvant systemic therapy for breast cancer in the Netherlands and its effect on mortality , 2004, British Journal of Cancer.
[134] S. Duffy,et al. Progression Rates of Colorectal Cancer by Dukes' Stage in a High‐Risk Group: Analysis of Selective Colorectal Cancer Screening , 2004, Cancer journal.
[135] Evaluation of cancer prevention strategies by computerized simulation model: an approach to lung cancer , 1991, Cancer Causes & Control.
[136] J. Faivre,et al. Cost-effectiveness analysis of fecal occult blood screening for colorectal cancer , 2004, International Journal of Technology Assessment in Health Care.
[137] Z. Philips,et al. An evaluation of liquid-based cytology and human papillomavirus testing within the UK cervical cancer screening programme , 2004, British Journal of Cancer.
[138] H. Adami,et al. Optimization of cervical cancer screening , 1992, Cancer Causes & Control.
[139] G. Leung,et al. Cost-effectiveness of organized versus opportunistic cervical cytology screening in Hong Kong. , 2004, Journal of public health.
[140] Simulation of Breast Cancer Screening: Quality Assessment of Two Protocols , 2004, Journal for healthcare quality : official publication of the National Association for Healthcare Quality.
[141] A. Fendrick,et al. Fecal DNA testing compared with conventional colorectal cancer screening methods: a decision analysis. , 2004, Gastroenterology.
[142] Barbara L. Smith,et al. Mammographic screening: Patterns of use and estimated impact on breast carcinoma survival , 2004, Cancer.
[143] Yen Lin Chia,et al. Simulation-based parameter estimation for complex models: a breast cancer natural history modelling illustration , 2004, Statistical methods in medical research.
[144] D. Hunter,et al. Simulation modeling of change to breast cancer detection age eligibility recommendations in Ontario, 2002-2021. , 2004, Cancer detection and prevention.
[145] M. Zelen,et al. Robust modeling in screening studies: estimation of sensitivity and preclinical sojourn time distribution. , 2005, Biostatistics.
[146] J. Berkhof,et al. Natural history and screening model for high‐risk human papillomavirus infection, neoplasia and cervical cancer in the Netherlands , 2005, International journal of cancer.
[147] Sue J Goldie,et al. Cost-effectiveness of cervical-cancer screening in five developing countries. , 2005, The New England journal of medicine.
[148] A. Miller,et al. Estimation of age‐specific sensitivity and sojourn time in breast cancer screening studies , 2005, Statistics in medicine.
[149] M. Zelen,et al. Inferring the natural time history of breast cancer: Implications for tumor growth rate and early detection , 2005, Breast Cancer Research and Treatment.
[150] Frank Castro,et al. The relation of breast cancer staging to screening protocol compliance: a computer simulation study , 2005, Comput. Biol. Medicine.
[151] H. Brenner,et al. A Simulation Model for Colorectal Cancer Screening: Potential of Stool Tests with Various Performance Characteristics Compared with Screening Colonoscopy , 2005, Cancer Epidemiology Biomarkers & Prevention.
[152] D. Berry,et al. Effect of screening and adjuvant therapy on mortality from breast cancer , 2005 .
[153] K. S. Ross,et al. Estimation of treatment benefits when PSA screening for prostate cancer is discontinued at different ages. , 2005, Urology.
[154] Yu Shen,et al. Nonparametric Estimation of Asymptomatic Duration from a Randomized Prospective Cancer Screening Trial , 2005, Biometrics.
[155] A Tsodikov,et al. A population model of prostate cancer incidence , 2006, Statistics in medicine.
[156] T. Chen,et al. Evolution of multiple disease screening in Keelung: a model for community involvement in health interventions? , 2006, Journal of medical screening.
[157] D. Dearnaley,et al. A model of the natural history of screen-detected prostate cancer, and the effect of radical treatment on overall survival , 2006, British Journal of Cancer.
[158] Jennifer Cullen,et al. The SPECTRUM population model of the impact of screening and treatment on U.S. breast cancer trends from 1975 to 2000: principles and practice of the model methods. , 2006, Journal of the National Cancer Institute. Monographs.
[159] N. Nagelkerke,et al. Breast Cancer Screening, Outside the Population-Screening Program, of Women from Breast Cancer Families without Proven BRCA1/BRCA2 Mutations: a Simulation Study , 2006, Cancer Epidemiology Biomarkers & Prevention.
[160] C. Earle,et al. Computed tomography screening for lung cancer in Hodgkin's lymphoma survivors: decision analysis and cost-effectiveness analysis. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.
[161] A. Berchuck,et al. Genomic tests for ovarian cancer detection and management. , 2006, Evidence report/technology assessment.
[162] Vipat Kuruchittham,et al. The Wisconsin Breast Cancer Epidemiology Simulation Model. , 2006, Journal of the National Cancer Institute. Monographs.
[163] P. Glynn,et al. A stochastic simulation model of U.S. breast cancer mortality trends from 1975 to 2000. , 2006, Journal of the National Cancer Institute. Monographs.
[164] H. D. de Koning,et al. Gleason score, age and screening: Modeling dedifferentiation in prostate cancer , 2006, International journal of cancer.
[165] K. Kerlikowske,et al. Cost-effectiveness of Extending Cervical Cancer Screening Intervals Among Women With Prior Normal Pap Tests , 2006, Obstetrics and gynecology.
[166] T. Chen,et al. Colorectal cancer screening with faecal occult blood test within a multiple disease screening programme: an experience from Keelung, Taiwan. , 2006, Journal of medical screening.
[167] M. Zelen,et al. A stochastic model for predicting the mortality of breast cancer. , 2006, Journal of the National Cancer Institute. Monographs.
[168] Harry J de Koning,et al. The MISCAN-Fadia continuous tumor growth model for breast cancer. , 2006, Journal of the National Cancer Institute. Monographs.
[169] H. D. de Koning,et al. Seventy‐five years is an appropriate upper age limit for population‐based mammography screening , 2006, International journal of cancer.
[170] J. Berkhof,et al. Evaluation of cervical screening strategies with adjunct high‐risk human papillomavirus testing for women with borderline or mild dyskaryosis , 2006, International journal of cancer.
[171] Maureen A Smith,et al. Retrospective cost-effectiveness analysis of screening mammography. , 2006, Journal of the National Cancer Institute.
[172] Eric J Feuer,et al. A comparative review of CISNET breast models used to analyze U.S. breast cancer incidence and mortality trends. , 2006, Journal of the National Cancer Institute. Monographs.
[173] A. Yakovlev,et al. The University of Rochester model of breast cancer detection and survival. , 2006, Journal of the National Cancer Institute. Monographs.
[174] M. Pitt,et al. Surveillance of Barrett's oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling. , 2006, Health technology assessment.
[175] Natasha K. Stout,et al. Chapter 7: The Wisconsin Breast Cancer Epidemiology Simulation Model , 2006 .
[176] Bruce L Daniel,et al. Cost-effectiveness of screening BRCA1/2 mutation carriers with breast magnetic resonance imaging. , 2006, JAMA.
[177] T. Chen,et al. Efficacy and cost-effectiveness of nationwide cervical cancer screening in Taiwan. , 2006, Journal of medical screening.
[178] Jeremy D Goldhaber-Fiebert,et al. Chapter 18: Public health policy for cervical cancer prevention: the role of decision science, economic evaluation, and mathematical modeling. , 2006, Vaccine.
[179] Lurdes Y. T. Inoue,et al. Modeling the impact of treatment and screening on U.S. breast cancer mortality: a Bayesian approach. , 2006, Journal of the National Cancer Institute. Monographs.
[180] J. Halliday,et al. Using record linkage and manual follow-up to evaluate the Victorian maternal serum screening quadruple test for Down's syndrome, trisomy 18 and neural tube defects , 2006, Journal of medical screening.
[181] G. Gazelle,et al. Use of modeling to evaluate the cost-effectiveness of cancer screening programs. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[182] Karen M Kuntz,et al. Multiparameter calibration of a natural history model of cervical cancer. , 2007, American journal of epidemiology.
[183] Sylvia K Plevritis,et al. A natural history model of stage progression applied to breast cancer , 2007, Statistics in medicine.
[184] Jeremy D Goldhaber-Fiebert,et al. Modeling human papillomavirus and cervical cancer in the United States for analyses of screening and vaccination , 2007, Population health metrics.
[185] M. Ezzati,et al. Development of an Empirically Calibrated Model of Gastric Cancer in Two High-Risk Countries , 2008, Cancer Epidemiology Biomarkers & Prevention.
[186] G Scott Gazelle,et al. Calibration of disease simulation model using an engineering approach. , 2009, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[187] Milton C. Weinstein,et al. Recent Developments in Decision-Analytic Modelling for Economic Evaluation , 2012, PharmacoEconomics.
[188] Richard G. White,et al. Calibrating Models in Economic Evaluation , 2012, PharmacoEconomics.